Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
11049.0000
-101.00
(
-0.91
%)
NSE
Nov 18, 2026
15:31 PM
95.64% Gain from 52W Low
Volume:
472.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
10 Nov 2025
11049.00
-0.91%
Divi's Laboratories (DIVI IN) Q2FY26 Result Update Peptides...
Accumulate:
Divi's Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 7050
Target
Prabhudas Lilladhar
Divi's Laboratories has gained
20.83%
in the last 1 Month
More from Divi's Laboratories Ltd.
Recommended
Market closes lower as IT, metal and financial stocks drag
Trendlyne Marketwatch |
18 Nov 2026, 03:55PM
Five stocks to buy from analysts this week - November 17, 2026
The Baseline |
17 Nov 2026, 05:57PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022